Bernstein Derek T, Weiner Bradley K, Tasciotti Ennio, Mathis Kenneth B
Houston Methodist Hospital, Department of Orthopaedic Surgery, 6550 Fannin Street, Smith Tower, Suite 2500, Houston, TX, 77030, United States.
Houston Methodist Hospital, Department of Orthopaedic Surgery, 6550 Fannin Street, Smith Tower, Suite 2500, Houston, TX, 77030, United States; The Methodist Hospital Research Institute, Department of Nanomedicine, 6670 Bertner Avenue, Houston, TX, 77030, United States.
Injury. 2016 Aug;47(8):1819-23. doi: 10.1016/j.injury.2016.05.034. Epub 2016 May 25.
The reported prognosis for recovery after peripheral nerve injury is remarkably poor. Deficits may persist for years, resulting in significant functional disability. Both corticosteroids and Erythropoietin have been investigated as neuroprotective agents; however, their efficacy in total hip and knee arthroplasty is not known. The purpose of this study was to evaluate the effect of systemically-administered Erythropoietin and tapered oral corticosteroids on the recovery of postoperative nerve palsies in the setting of total hip and knee arthroplasty.
Eleven patients sustaining postoperative peripheral nerve injuries after total hip or knee arthroplasty were treated acutely with Erythropoietin and tapered oral steroids. Motor and sensory function was assessed clinically pre- and postoperatively until complete motor recovery or for a minimum of 1 year.
Motor loss was complete in seven (64%) patients and partial in four (36%). Seven (64%) patients' symptoms affected the common peroneal nerve distribution and four (36%) had concomitant tibial nerve involvement. Eight (73%) patients experienced full motor recovery at an average of 39 days (range: 3-133 days), and three (27%) had near-complete motor recovery. At final follow up, no patient required assistive devices for ambulation.
Administration of Erythropoietin coupled with oral tapered steroids for patients sustaining iatrogenic nerve injuries in total hip and knee arthroplasty demonstrated faster and more complete recovery of motor and sensory function compared to previous reports in the literature. This study highlights the importance of further investigation to define the role of each in the setting of acute postoperative nerve palsies.
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
据报道,周围神经损伤后的恢复预后非常差。功能缺损可能会持续数年,导致严重的功能残疾。皮质类固醇和促红细胞生成素都已作为神经保护剂进行了研究;然而,它们在全髋关节和膝关节置换术中的疗效尚不清楚。本研究的目的是评估全身应用促红细胞生成素和逐渐减量的口服皮质类固醇对全髋关节和膝关节置换术后神经麻痹恢复的影响。
11例全髋关节或膝关节置换术后发生周围神经损伤的患者接受了促红细胞生成素和逐渐减量的口服类固醇的急性治疗。术前和术后对运动和感觉功能进行临床评估,直至运动功能完全恢复或至少持续1年。
7例(64%)患者运动功能完全丧失,4例(36%)部分丧失。7例(64%)患者的症状影响腓总神经分布区,4例(36%)伴有胫神经受累。8例(73%)患者平均在39天(范围:3 - 133天)实现了完全运动功能恢复,3例(27%)实现了近乎完全的运动功能恢复。在最后随访时,没有患者需要辅助器械进行行走。
与文献中先前的报道相比,对于全髋关节和膝关节置换术中发生医源性神经损伤的患者,应用促红细胞生成素联合口服逐渐减量的类固醇显示出运动和感觉功能恢复更快且更完全。本研究强调了进一步研究以明确每种药物在急性术后神经麻痹中的作用的重要性。
治疗性四级。有关证据水平的完整描述,请参阅作者指南。